Crossref
journal-article
Elsevier BV
Journal of Molecular Graphics and Modelling (78)
References
66
Referenced
21
{'key': '10.1016/j.jmgm.2005.10.002_bib1', 'first-page': '113', 'article-title': 'Calculating binding free energy in protein–ligand interaction', 'volume': 'vol. 1', 'author': 'Raha', 'year': '2005'}
/ Calculating binding free energy in protein–ligand interaction by Raha (2005)10.1021/cr00023a004
/ Chem. Rev. / Free energy calculations: applications to chemical and biochemical phenomena by Kollman (1993)10.2174/1386207013330661
/ Comb. Chem. High Throughput Screening / The linear interaction energy method for predicting ligand binding free energies by Aqvist (2001)10.1023/A:1027251719816
/ Perspect. Drug Discov. / A priori prediction of ligand affinity by energy minimization by Holloway (1998)10.1021/jp011480z
/ J. Phys. Chem. B / New linear interaction method for binding affinity calculations using a continuum solvent model by Zhou (2001)10.1021/j100026a034
/ J. Phys. Chem. / An extended linear response method for determining free energies of hydration by Carlson (1995)10.1021/jm020513b
/ J. Med. Chem. / Calculation of the binding affinity of beta-secretase inhibitors using the linear interaction energy method by Tounge (2003)10.1016/j.bmcl.2004.07.044
/ Bioorg. Med. Chem. Lett. / Modeling the binding affinities of β-secretase inhibitors: application to subsite specificity by Rajamani (2004)10.1021/jm049726m
/ J. Med. Chem. / Efficient evaluation of binding free energy using continuum electrostatics by Huang (2004)10.1023/A:1007930623000
/ J. Comput. Aided Mol. Des. / Ligand binding affinity prediction by linear interaction energy methods by Hansson (1998)10.1016/S0065-3233(03)66004-3
/ Adv. Protein Chem. / Free energy calculations and ligand binding by Brandsdal (2003)10.1002/(SICI)1097-0134(19990215)34:3<395::AID-PROT11>3.0.CO;2-4
/ Proteins Struct. Funct. Genet. / What determines the van der Waals coefficient beta in the LIE (linear interaction energy) method to estimate binding free energies using molecular dynamics simulations? by Wang (1999)10.1021/jm960684e
/ J. Med. Chem. / Binding affinities for sulfonamide inhibitors with human thrombin using Monte Carlo simulations with a linear response method by Jones-Hertzog (1997)10.1016/S0960-894X(01)00825-3
/ Bioorg. Med. Chem. Lett. / Estimation of binding affinities for Celecoxib analogues with COX-2 via Monte Carlo-extended linear response by Wesolowski (2002)10.1016/S0968-0896(99)00015-2
/ Bioorg. Med. Chem. / Estimation of the binding affinities of FKBP12 inhibitors using a linear response method by Lamb (1999)10.1021/jm9804174
/ J. Med. Chem. / Prediction of binding affinities for TIBO inhibitors of HIV-1 reverse transcriptase using Monte Carlo simulations in a linear response method by Smith (1998)10.1038/399a023
/ Nature / Translating cell biology into therapeutic advances in Alzheimer's disease by Selkoe (1999)10.1152/physrev.2001.81.2.741
/ Physiol. Rev. / Alzhiemer's disease: genes, proteins and therapy by Selkoe (2001)10.1073/pnas.96.20.11049
/ Proc. Natl. Acad. Sci. U.S.A. / Cellular mechanisms of β-Amyloid production and secretion by Sinha (1999)10.1016/S0169-409X(02)00157-6
/ Adv. Drug Del. Rev. / β-Secretase (BACE) as a drug target for Alzheimer's disease by Vassar (2002)10.1016/S0896-6273(00)00051-9
/ Neuron / Abeta-generating enzymes: recent advances in beta- and gamma-secretase research by Vassar (2000){'key': '10.1016/j.jmgm.2005.10.002_bib22', 'first-page': '157', 'article-title': "The beta-secretase BACE. A prime drug target for Alzheimer's disease", 'volume': '17', 'author': 'Vassar', 'year': '2001', 'journal-title': 'J. Mol. Spectrosc.'}
/ J. Mol. Spectrosc. / The beta-secretase BACE. A prime drug target for Alzheimer's disease by Vassar (2001){'key': '10.1016/j.jmgm.2005.10.002_bib23', 'first-page': '259', 'article-title': "Potential treatment opportunities for Alzheimer's disease through inhibition of secretases and Abeta immunization", 'volume': '17', 'author': 'Schenk', 'year': '2001', 'journal-title': 'J. Mol. Spectrosc.'}
/ J. Mol. Spectrosc. / Potential treatment opportunities for Alzheimer's disease through inhibition of secretases and Abeta immunization by Schenk (2001)10.1016/S0065-7743(00)35005-9
/ Annu. Rep. Med. Chem. / Secretase inhibitors as therapeutics for Alzheimer's disease by Olson (2000)10.1172/JCI14402
/ J. Clin. Invest. / Spotlight on BACE: the secretases as targets for treatment in Alzheimer's disease by Dingwall (2001)10.1126/science.290.5489.150
/ Science (Washington DC) / Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor by Hong (2000)10.1021/bi026232n
/ Biochemistry / Crystal structure of memapsin 2 (beta-Secretase) in complex with an inhibitor OM00-3 by Hong (2002)10.1021/jm0101803
/ J. Med. Chem. / Structure-based design: potent inhibitors of human brain memapsin 2 (beta-Secretase) by Ghosh (2001)10.1016/j.bmcl.2004.10.084
/ Bioorg. Med. Chem. Lett. / Structure-based design of cycloamide-urethane-derived novel inhibitors of human brain memapsin 2 (β-secretase) by Ghosh (2005)10.1021/jm0155695
/ J. Med. Chem. / Design of substrate-based inhibitors of human β.-Secretase by Tung (2002)10.1074/jbc.M101896200
/ J. Biol. Chem. / Mechanism of inhibition of β-site amyloid precursor protein-cleaving enzyme (BACE) by a statine-based peptide by Marcinkeviciene (2001)10.1006/jmbi.2000.3860
/ J. Mol. Biol. / Modeling of substrate specificity of the Alzheimer's disease amyloid precursor protein β-Secretase by Sauder (2000)10.1021/jm0101803
/ J. Med. Chem. / Structure-based design: potent inhibitors of human brain memapsin 2 (beta-secretase) by Ghosh (2001)10.1021/bi015546s
/ Biochemistry / Subsite specificity of memapsin 2 (β-Secretase): Implications for inhibitor design by Turner (2001)10.1517/13543784.10.4.593
/ Expert Opin. Inv. Drug / β-Amyloid therapies in Alzheimer's disease by Jhee (2001)10.1021/ja000300g
/ J. Am. Chem. Soc. / Design of potent inhibitors for human brain memapsin 2 (beta-secretase) by Ghosh (2000)10.1006/bbrc.2000.2098
/ Biochem. Biophys. Res. Commun. / Inhibitors of β-amyloid formation based on the β-secretase cleavage site by Abbenante (2000)10.1021/ja0304493
/ J. Am. Chem. Soc. / Determination of the active site protonation state of β-Secretase from molecular dynamics simulation and docking experiment: implications for structure-based inhibitor design by Park (2003)10.2174/1568026024607490
/ Curr. Top. Med. Chem. / Inhibition of BACE, a promising approach to Alzheimer by Roggo (2002)10.1039/B304842J
/ Org. Biomol. Chem. / Synthesis of potent β-secretase inhibitors containing a hydroxyethylamine dipeptide isostere and their structure-activity relationship studies by Tamamura (2003)10.1074/jbc.M210471200
/ J. Biol. Chem. / Kinetic Studies on β-Site amyloid precursor protein-cleaving enzyme (BACE) by Toulokhonova (2003)10.1021/jm0304008
/ J. Med. Chem. / Design and synthesis of hydroxyethylene-based peptidomimetic inhibitors of human β-Secretase by Hom (2004)10.1021/jm049817j
/ J. Med. Chem. / Modeling the protonation states of the catalytic aspartates in β-Secretase by Rajamani (2004)10.1016/j.bmcl.2003.09.053
/ Bioorg. Med. Chem. Lett. / KMI-008, A novel β-secretase inhibitor containing a hydroxymethylcarbonyl isostere as a transition-state mimic: design and synthesis of substrate-based octapeptides by Shuto (2003)10.1021/jm0155695
/ J. Med. Chem. / Design of substrate-based inhibitors of human β-secretase by Tung (2002)10.1021/bi0151465
/ Biochemistry / Subsite specificity of memapsin 2 (β-Secretase): Implications for inhibitor design by Turner (2001){'key': '10.1016/j.jmgm.2005.10.002_bib47', 'first-page': '1', 'article-title': 'Human β-secretase (BACE) and BACE inhibitors', 'volume': '46', 'author': 'Varghese', 'year': '2003', 'journal-title': 'J. Med. Chem.'}
/ J. Med. Chem. / Human β-secretase (BACE) and BACE inhibitors by Varghese (2003)10.1021/jm050142+
/ J. Med. Chem. / Structure-based design synthesis, and memapsin 2 (BACE) inhibitory activity of carbocyclic and heterocyclic peptidomimetics by Hanessian (2005){'key': '10.1016/j.jmgm.2005.10.002_bib49', 'first-page': '515', 'article-title': 'Synthesis of β-secretase inhibitors containing a hydroxyethylamine dipeptide isostere and their structure-activity relationship studies', 'volume': '41st', 'author': 'Kato', 'year': '2005', 'journal-title': 'Pep. Sci.'}
/ Pep. Sci. / Synthesis of β-secretase inhibitors containing a hydroxyethylamine dipeptide isostere and their structure-activity relationship studies by Kato (2005)10.1021/jm049379g
/ J. Med. Chem. / Structure-based design of potent and selective cell-permeable inhibitors of human β-Secretase (BACE-1) by Stachel (2004)10.1016/j.bmcl.2003.09.037
/ Bioorg. Med. Chem. Lett. / Design and synthesis of statine-containing BACE inhibitors by Hu (2003)10.1021/jm0155695
/ J. Med. Chem. / Design of substrate-based inhibitors of human β-Secretase by Tung (2002)10.1021/jm0101803
/ J. Med. Chem. / Structure-based design: potent inhibitors of human brain memapsin 2 (β-secretase) by Ghosh (2001)10.1021/jm050499d
/ J. Med. Chem. / Discovery of cell-permeable non-peptide inhibitors of β-secretase by high-throughput docking and continuum rlectrostatics calculations by Huang (2005)10.1016/j.bmc.2005.01.002
/ Bioorg. Med. Chem. / Molecular docking and 3D-QSAR studies on the binding mechanism of statine-based peptidomimetics with β-secretase by Zuo (2005)10.1016/j.bmcl.2004.09.090
/ Bioorg. Med. Chem. Lett. / Design and synthesis of highly active Alzheimer's β-secretase (BACE1) inhibitors, KMI-420 and KMI-429, with enhanced chemical stability by Kimura (2005)10.1006/jmbi.2000.3860
/ J. Mol. Biol. / Modeling of substrate specificity of the Alzheimer's disease amyloid precursor protein β-Secretase by Sauder (2000)10.2174/0929867023370149
/ Cur. Med. Chem. / β-secretase as a therapeutic target for inhibitor drugs by Ghosh (2002)10.1016/j.jmb.2004.08.018
/ J. Mol. Biol. / Apo and inhibitor complex structures of BACE (β-secretase) by Patel (2004)- Maestro, 2.0 2.0, 2001. Schrodinger, Inc., 1500 SW First Ave., Suite 1180, Portland, OR 97201.
10.1021/ja00214a001
/ J. Am. Chem. Soc. / The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin by Jorgensen (1988)10.1021/jp961992r
/ J. Phys. Chem. A / The GB/SA continuum model for solvation. a fast analytical method for the calculation of approximate Born radii by Qui (1997)- FistDiscovery, 2.0 2.0, 2001. Schrodinger, Inc., 1500 SW First Ave., Suite 1180, Portland, OR 97201.
10.1023/A:1007929626986
/ J. Comput. Aided Mol. Des. / Computation of affinity and selectivity: binding of 2,4-diaminopteridine and 2,4-diaminoquinazoline inhibitors to dihydrofolate reductases by Marelius (1998)10.1021/jp953640a
/ J. Phys. Chem. / Validity of electrostatic linear response in polar solvents by Aqvist (1996)10.1002/(SICI)1096-987X(19961115)17:14<1587::AID-JCC1>3.0.CO;2-H
/ J. Comput. Chem. / Calculation of sbsolute binding free energies for charged ligands and effects of long-range electrostatic interactions by Aqvist (1996)
Dates
Type | When |
---|---|
Created | 19 years, 9 months ago (Nov. 16, 2005, 7:24 a.m.) |
Deposited | 2 years, 3 months ago (May 5, 2023, 9:04 a.m.) |
Indexed | 2 weeks, 5 days ago (Aug. 3, 2025, 12:05 a.m.) |
Issued | 19 years, 3 months ago (May 1, 2006) |
Published | 19 years, 3 months ago (May 1, 2006) |
Published Print | 19 years, 3 months ago (May 1, 2006) |
@article{Tounge_2006, title={Linear interaction energy models for β-secretase (BACE) inhibitors: Role of van der Waals, electrostatic, and continuum-solvation terms}, volume={24}, ISSN={1093-3263}, url={http://dx.doi.org/10.1016/j.jmgm.2005.10.002}, DOI={10.1016/j.jmgm.2005.10.002}, number={6}, journal={Journal of Molecular Graphics and Modelling}, publisher={Elsevier BV}, author={Tounge, Brett A. and Rajamani, Ramkumar and Baxter, Ellen W. and Reitz, Allen B. and Reynolds, Charles H.}, year={2006}, month=may, pages={475–484} }